drugset / Trial / NCT01373515
Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia
Non-randomizedSingle-groupOpen-labelOther
Summary
This is an open label phase 1 feasibility and safety dose escalation study. The main objective is to evaluate the safety of DCP-001 intradermal vaccination in patients with AML.
Timeline
- Start
- 2011-04
- Primary completion
- 2013-02
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DCP-001 | Vaccine | 1e+07 cells | Intravitreal |
| Subject | DCP-001 | Vaccine | 2.5e+07 cells | Intravitreal |
| Subject | DCP-001 | Vaccine | 5e+07 cells | Intravitreal |